A study comparing ways to assess breast cancer risk (CanRisk-ClinGen)

This study is looking at a pathway using the CanRisk assessment tool to assess breast cancer risk. The team are comparing this pathway to the usual pathway. A pathway describes the different steps you and your team need to take for you to get the care and treatment you need.

This study is open to women who have a family history of breast cancer and have been referred to an NHS Clinical Genetic Service.